---
title: "SANXING Medical's subsidiary won the bid for the U.S. Nexgrid smart meter framework project, with a contract amount of USD 29.555 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250764480.md"
description: "According to the announcement from Zhitong Finance APP, SANXING Medical announced that its subsidiary, Nansen Instrumentos de Precision de Mexico (hereinafter referred to as \"Nansen Mexico\"), won the bid for the US Nexgrid smart meter framework project, with a total contract amount of USD 29.555 million, approximately RMB 212 million"
datetime: "2025-07-30T10:47:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250764480.md)
  - [en](https://longbridge.com/en/news/250764480.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250764480.md)
generator: "portal-rs"
---

# SANXING Medical's subsidiary won the bid for the U.S. Nexgrid smart meter framework project, with a contract amount of USD 29.555 million

According to the announcement from Zhitong Finance APP, SANXING Medical (601567.SH) announced that its subsidiary, Nansen Instrumentos de Precision de Mexico (hereinafter referred to as "Nansen Mexico"), won the bid for the U.S. Nexgrid smart meter framework project, with a total contract amount of USD 29.555 million, approximately RMB 212 million

### Related Stocks

- [601567.CN](https://longbridge.com/en/quote/601567.CN.md)

## Related News & Research

- [Air Tanzania becomes first airline to halt flights to Russia after Zelenskiy warning](https://longbridge.com/en/news/298013085.md)
- [Fortum wins regulatory clearance for NOK 47-a-share Elmera bid](https://longbridge.com/en/news/297866660.md)
- [DOF Group CFO Lundberg sells 25,000 shares at NOK 132 each](https://longbridge.com/en/news/297912831.md)
- [Fed ends enforcement action against United Texas Bank](https://longbridge.com/en/news/298057655.md)
- [CVC Strategic Opportunities makes first outside equity investment in Unitex alongside Potack family](https://longbridge.com/en/news/297911948.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**